Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefanie R Mullins

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Microarrays for protease detection in tissues and cellsKamiar Moin, Donald Schwartz, Stefanie R Mullins, et al.
Biological Chemistry|May 14, 2013
Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsinsStefanie R Mullins, Mansoureth Sameni, Galia Blum, et al.
BMC Cancer|June 15, 2011
FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cellsHyung-Ok Lee, Stefanie R Mullins, Janusz Franco-Barraza, et al.
Nature Chemical Biology|January 13, 2006
Dynamic imaging of protease activity with fluorescently quenched activity-based probesGalia Blum, Stefanie R Mullins, Kinneret Keren, et al.
Clinical & Experimental Metastasis|December 17, 2008
Imaging and quantifying the dynamics of tumor-associated proteolysisMansoureh Sameni, Dora Cavallo-Medved, Julie Dosescu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 30, 2012
Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screensJiping Zhang, Matthildi Valianou, Heidi Simmons, et al.
Clinical & Translational Immunology|October 2, 2020
Intratumoral administration of the Toll-like receptor 7/8 agonist 3M-052 enhances interferon-driven tumor immunogenicity and suppresses metastatic spread in preclinical triple-negative breast cancerDamien J Zanker, Alex J Spurling, Natasha K Brockwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2017
Optoacoustic Detection of Early Therapy-Induced Tumor Cell Death Using a Targeted Imaging AgentBangwen Xie, Michal R Tomaszewski, André A Neves, et al.
Cancer Biology & Therapy|November 23, 2007
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancerKalyani Narra, Stefanie R Mullins, Hyung-Ok Lee, et al.
Journal for Immunotherapy of Cancer|September 13, 2019
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapiesStefanie R Mullins, John P Vasilakos, Katharina Deschler, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Microarrays for protease detection in tissues and cellsKamiar Moin, Donald Schwartz, Stefanie R Mullins, et al.
Biological Chemistry|May 14, 2013
Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsinsStefanie R Mullins, Mansoureth Sameni, Galia Blum, et al.
BMC Cancer|June 15, 2011
FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cellsHyung-Ok Lee, Stefanie R Mullins, Janusz Franco-Barraza, et al.
Nature Chemical Biology|January 13, 2006
Dynamic imaging of protease activity with fluorescently quenched activity-based probesGalia Blum, Stefanie R Mullins, Kinneret Keren, et al.
Clinical & Experimental Metastasis|December 17, 2008
Imaging and quantifying the dynamics of tumor-associated proteolysisMansoureh Sameni, Dora Cavallo-Medved, Julie Dosescu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 30, 2012
Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screensJiping Zhang, Matthildi Valianou, Heidi Simmons, et al.
Clinical & Translational Immunology|October 2, 2020
Intratumoral administration of the Toll-like receptor 7/8 agonist 3M-052 enhances interferon-driven tumor immunogenicity and suppresses metastatic spread in preclinical triple-negative breast cancerDamien J Zanker, Alex J Spurling, Natasha K Brockwell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2017
Optoacoustic Detection of Early Therapy-Induced Tumor Cell Death Using a Targeted Imaging AgentBangwen Xie, Michal R Tomaszewski, André A Neves, et al.
Cancer Biology & Therapy|November 23, 2007
Phase II trial of single agent Val-boroPro (Talabostat) inhibiting Fibroblast Activation Protein in patients with metastatic colorectal cancerKalyani Narra, Stefanie R Mullins, Hyung-Ok Lee, et al.
Journal for Immunotherapy of Cancer|September 13, 2019
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapiesStefanie R Mullins, John P Vasilakos, Katharina Deschler, et al.
Pageof 1